Neurocrine Biosciences (NBIX) Gains from Sales and Divestitures (2010 - 2026)
Neurocrine Biosciences (NBIX) posted Gains from Sales and Divestitures of $28.6 million for Q1 2026.
Powered by 
Analysis
Neurocrine Biosciences (NBIX) Gains from Sales and Divestitures (2010 - 2026) Analysis & Trends
For FY2018, Neurocrine Biosciences' Gains from Sales and Divestitures came in at $760,000, down 63.9% from FY2017.
- Annual Gains from Sales and Divestitures shows a five-year compound annual growth rate of -24.8% (FY2013 to FY2018).
- In prior years, Neurocrine Biosciences' Gains from Sales and Divestitures was $2.1 million in FY2017 (-38.7%), $3.43 million in FY2016 (+2.9%), $3.33 million in FY2015 (+3.5%) and $3.22 million in FY2014 (+1.6%).
- The Q1 2026 figure stands as the highest quarterly Gains from Sales and Divestitures in data going back to Q3 2010.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn |
| 10 | Neurocrine Biosciences | 14.55 Bn | 10.25 Bn | 935.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 28.60 Mn |
| Jun 30, 2018 | 147,000.00 |
| Mar 31, 2018 | 201,000.00 |
| Dec 31, 2017 | 156,000.00 |
| Sep 30, 2017 | 188,000.00 |
| Jun 30, 2017 | 881,000.00 |
| Mar 31, 2017 | 879,000.00 |
| Dec 31, 2016 | 863,000.00 |
| Sep 30, 2016 | 844,000.00 |
| Jun 30, 2016 | 868,000.00 |
| Mar 31, 2016 | 856,000.00 |
| Dec 31, 2015 | 838,000.00 |
| Sep 30, 2015 | 828,000.00 |
| Jun 30, 2015 | 829,000.00 |
| Mar 31, 2015 | 839,000.00 |
| Dec 31, 2014 | 812,000.00 |
| Sep 30, 2014 | 806,000.00 |
| Jun 30, 2014 | 810,000.00 |
| Mar 31, 2014 | 794,000.00 |
| Dec 31, 2013 | 788,000.00 |
API Access
Neurocrine Biosciences Gains from Sales and Divestitures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NBIX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gains-from-sales-and-divestitures", "ticker": "NBIX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=NBIX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();